Jonathan Glenn

 

Jonathan Glenn

Chief Executive Officer

Appointed to the Board

11 September 2006. CEO since December 2007

Current Role

Chief Executive Officer

Committees

Mr Glenn is a member of the Nomination Committee and the Corporate Responsibility Committee.

Skills & Experience

Jonathan was Group Finance Director of Consort Medical plc from September 2006 to December 2007 until he took up the position of Chief Executive Officer in December 2007. Prior to joining Consort Medical plc, Jonathan was global Head of Finance at Celltech Group plc and later Chief Financial Officer of Akubio Ltd, a Cambridge-based developer of instrumentation for the life sciences industry. Jonathan joined Tissue Regenix Group plc as a non-executive director in January 2016 and is an investor director of Atlas Genetics Limited.

Jonathan is a member of the Institute of Chartered Accountants in England and Wales.